Branded generics drive earnings

Company
30 Oct 2024
5 Min read 
  • Ajanta Pharma's 2QFY25 results and financials update.
  •  Sales and EBITDA growth in different segments.
  •  Valuation and view: Reiterate BUY.
  •  Highlights from the management commentary.
  •  Financials and valuations ratios.
  •  Consolidated cash flow statement.
Login / Open Demat Account to read the report

Never Miss Out on Hot Market Updates

Get exclusive market news delivered to your inbox - on priority